Recent US Regulatory Updates & Future Global Implications for EAPs
- Understanding how EAPs are shifting to integrated access and evidence models generating real-world data
- Accounting for how regulators are formalizing expectations on justification, risk– benefit, and alignment with development strategy
- Learning how external pressures shape expanded access, including MFN/pricing signals, FDA changes, and geopolitics